Global Alzheimer Drugs Market to Reach USD 6537.0 Million by 2021, Expects Growth Driven by Rising Prevalence of Alzheimer's Disease and Advancements in Telehealth Services

Strategic Insights -

The global Alzheimer drugs market is expected to grow significantly, driven by the rising prevalence of Alzheimer's disease and advancements in telehealth services. The market was valued at USD 6537.0 Million in 2021 and is anticipated to reach USD 6537.0 Million by the end of 2027, with a compound annual growth rate (CAGR) of 5.5%. The growth is attributed to the increasing prevalence of Alzheimer's disease, which is a complex and multifactorial disorder. The global Alzheimer drugs market is segmented by drug class, distribution channel, and region.

Key Takeaways:

  • The global Alzheimer drugs market was valued at USD 6537.0 Million in 2021.
  • The market is expected to reach USD 6537.0 Million by the end of 2027, with a CAGR of 5.5%.
  • The rising prevalence of Alzheimer's disease is driving the growth of the market.
  • Advancements in telehealth services, including the use of remote delivery of clinical and non-clinical services through tele and digital communication technologies, are expected to propel market growth.
  • Key players in the market include AbbVie Inc., F. Hoffman-La Roche Ltd., Novartis AG, Biogen, and Pfizer Inc.
  • The market is segmented by drug class, including cholinergic, memantine, combined drugs, and others.
  • By distribution channel, the market is segmented into hospitals pharmacy, retail pharmacy, and online pharmacy.
  • The North America Alzheimer drugs market is expected to be the largest market, followed by Europe and Asia Pacific.

Statistics:

  • Global Alzheimer drugs market size: USD 6537.0 Million in 2021.
  • Market growth rate: 5.5% CAGR by 2027.
  • Key players: AbbVie Inc., F. Hoffman-La Roche Ltd., Novartis AG, Biogen, and Pfizer Inc.
  • Market segmentation: by drug class, distribution channel, and region.
  • North America Alzheimer drugs market size: expected to reach USD 6537.0 Million by 2027.

Sources:

  • "Global Alzheimer Drugs Market (2022 Edition) - Analysis By Drug Class (Cholinergic, Memantine, Combined Drugs, Others), Distribution Channel, By Region, By Country: Market Insights, Pipeline and Forecast with Impact of Covid-19 (2022-2027)".
  • Research and Markets.
  • "Global Alzheimer Drugs Market to Reach USD 6537.0 Million by 2021, Expects Growth Driven by Rising Prevalence of Alzheimer's Disease and Advancements in Telehealth Services".
  • Research and Markets.